Stay updated on Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy

Sign up to get notified when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    - Added clarifications about how publications are displayed (voluntary input and PubMed auto-fill) and updated the page revision to v3.3.2. - Removed older wording about publications and PubMed data sources, and the v3.2.0 revision note.
    Difference
    0.1%
    Check dated 2025-11-25T11:00:14.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page no longer shows the general notice about a lapse in government funding and potential delays, which is a site-wide informational banner rather than study-specific content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:00:00.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new publication entry was added to the Publications section: Audhya I et al., Neurol Ther (online ahead of print, 2025) ‘Caregiver-reported Patient Experiences with Duchenne Muscular Dystrophy: Qualitative In-trial Interviews 1 Year After Delandistrogene Moxeparvovec in the Pivotal EMBARK Trial’, doi: 10.1007/s40120-025-00842-7.
    Difference
    0.0%
    Check dated 2025-11-11T02:24:42.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    No additions or deletions are shown on the page; the content appears unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T20:58:21.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    2%
    Check dated 2025-10-06T05:24:57.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.3%
    Check dated 2025-09-29T03:02:57.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.